uniQure (QURE)
Develops one-time AAV gene therapies for serious diseases with unmet needs.
$45.70
After-hours close+0.43 (+0.95%)
At close$45.27(+2.17%)
Something off on this page? Send us feedback.
Next report
Nov 9, 26
in 48 days
EPS estimate
−$0.84
Revenue estimate
$6.2M
Fiscal quarter
Q3 FY26
EPSReportedEstimate
Feb '25May '25Jul '25Nov '25Mar '26May '26Jul '26Nov '26
Reported−$1.50−$0.82−$0.69−$1.38−$0.56−$0.85−$1.22Pending
Estimate−$0.60−$1.07−$0.89−$0.85−$0.93−$0.88−$0.82−$0.84
Surprise−150.0%+23.4%+22.5%−62.4%+39.8%+3.4%−48.4%—
RevenueReportedEstimate
Feb '25May '25Jul '25Nov '25Mar '26May '26Jul '26Nov '26
Reported$5.2M$1.6M$5.3M$3.7M$5.6M$3.6M$5.8MPending
Estimate$18.4M$5.9M$4.6M$4.8M$5.3M$5.2M$5.4M$6.2M
Surprise−71.7%−73.4%+13.7%−23.6%+4.5%−31.6%+7.2%—
HistoryUpcoming
| Date / Period | Estimate | Reported | Surprise |
|---|---|---|---|
| Sep 2028 | −$0.96 | — | — |
| Jun 2028 | −$0.91 | — | — |
| Mar 2028 | −$0.88 | — | — |
| Dec 2027 | −$0.46 | — | — |
| Sep 2027 | −$0.91 | — | — |
| Jun 2027 | −$1.05 | — | — |
| Mar 2027 | −$1.11 | — | — |
| Dec 2026 | −$0.90 | — | — |
| Nov 2026 | −$0.84 | — | — |
| Jul 2026 | −$0.82 | −$1.22 | −48.4% |
| May 2026 | −$0.88 | −$0.85 | +3.4% |
| Mar 2026 | −$0.93 | −$0.56 | +39.8% |
| Nov 2025 | −$0.85 | −$1.38 | −62.4% |
| Jul 2025 | |||
| May 2025 | |||
| Feb 2025 | |||
| Nov 2024 | |||
| Aug 2024 | |||
| May 2024 | |||
| Feb 2024 | |||
| Nov 2023 | |||
| Aug 2023 | |||
| May 2023 | |||
| Feb 2023 | |||
| Nov 2022 | |||
| Aug 2022 | |||
| May 2022 | |||
| Feb 2022 | |||
| Oct 2021 | |||
| Jul 2021 | |||
| May 2021 | |||
| Mar 2021 | |||
| Oct 2020 | |||
| Jul 2020 | |||
| Apr 2020 | |||
| Mar 2020 | |||
| Oct 2019 | |||
| Jul 2019 | |||
| Apr 2019 | |||
| Feb 2019 | |||
| Nov 2018 | |||
| Aug 2018 | |||
| Apr 2018 | |||
| Mar 2018 | |||
| Nov 2017 | |||
| Aug 2017 | |||
| May 2017 | |||
| Mar 2017 | |||
| Nov 2016 | |||
| Aug 2016 | |||
| May 2016 | |||
| Apr 2016 | |||
| Nov 2015 | |||
| Aug 2015 |
| Date / Period | EPS est | EPS | Surprise | Revenue est | Revenue | Surprise | Reaction |
|---|---|---|---|---|---|---|---|
| Sep 2028 | −$0.96 | — | — | $2.3M | — | — | — |
| Jun 2028 | −$0.91 | — | — | $2.6M | — | — | — |
| Mar 2028 | −$0.88 | — | — | $2.9M | — | — | — |
| Dec 2027 | −$0.46 | — | — | $64.4M | — | — | — |
| Sep 2027 | −$0.91 | — | — | $24.6M | — | — | — |
| Jun 2027 | −$1.05 | — | — | $15.6M | — | — | — |
| Mar 2027 | −$1.11 | — | — | $8.8M | — | — | — |
| Dec 2026 | −$0.90 | — | — | $7.8M | — | — | — |
| Nov 9, 2026 | −$0.84 | — | — | $6.2M | — | — | — |
| Jul 29, 2026 | −$0.82 | −$1.22 | −48.4% | $5.4M | $5.8M | +7.2% | +9.3% |
| May 5, 2026 | −$0.88 | −$0.85 | +3.4% | $5.2M | $3.6M | −31.6% | +2.3% |
| Mar 2, 2026 | −$0.93 | −$0.56 | +39.8% | $5.3M | $5.6M | +4.5% | −32.8% |
| Nov 10, 2025 | −$0.85 | −$1.38 | −62.4% | $4.8M | $3.7M | −23.6% | −5.9% |
| Jul 29, 2025 | |||||||
| May 9, 2025 | |||||||
| Feb 27, 2025 | |||||||
| Nov 5, 2024 | |||||||
| Aug 1, 2024 | |||||||
| May 7, 2024 | |||||||
| Feb 28, 2024 | |||||||
| Nov 7, 2023 | |||||||
| Aug 1, 2023 | |||||||
| May 9, 2023 | |||||||
| Feb 27, 2023 | |||||||
| Nov 2, 2022 | |||||||
| Aug 8, 2022 | |||||||
| May 2, 2022 | |||||||
| Feb 25, 2022 | |||||||
| Oct 25, 2021 | |||||||
| Jul 26, 2021 | |||||||
| May 10, 2021 | |||||||
| Mar 1, 2021 | |||||||
| Oct 27, 2020 | |||||||
| Jul 30, 2020 | |||||||
| Apr 29, 2020 | |||||||
| Mar 2, 2020 | |||||||
| Oct 28, 2019 | |||||||
| Jul 29, 2019 | |||||||
| Apr 29, 2019 | |||||||
| Feb 28, 2019 | |||||||
| Nov 6, 2018 | |||||||
| Aug 8, 2018 | |||||||
| Apr 30, 2018 | |||||||
| Mar 14, 2018 | |||||||
| Nov 1, 2017 | |||||||
| Aug 8, 2017 | |||||||
| May 9, 2017 | |||||||
| Mar 15, 2017 | |||||||
| Nov 22, 2016 | |||||||
| Aug 25, 2016 | |||||||
| May 31, 2016 | |||||||
| Apr 4, 2016 | |||||||
| Nov 30, 2015 | |||||||
| Aug 27, 2015 |